Neuroendovascular Coil Market Report 2025

This report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

The neuroendovascular coil market size has grown strongly in recent years. It will grow from $1.29 billion in 2024 to $1.4 billion in 2025 at a compound annual growth rate (CAGR) of 9.2%. The growth in the historic period can be attributed to increasing incidence of neurovascular diseases, growing aging population, improved diagnostic technologies, expansion of neurointerventional facilities, awareness and education initiatives, regulatory approvals and standards.

The neuroendovascular coil market size is expected to see strong growth in the next few years. It will grow to $1.87 billion in 2029 at a compound annual growth rate (CAGR) of 7.4%. The growth in the forecast period can be attributed to continuous rise in neurovascular cases, expansion of neurointerventional services, focus on early intervention, global healthcare infrastructure growth, patient-centric care trends, international collaborations in research. Major trends in the forecast period include advancements in detachable neuroendovascular coils, rise in utilization of liquid embolics, development of bioactive and bioabsorbable coils, integration of dual-layer coil technologies, focus on flow diverters for aneurysm treatment.

The increasing prevalence of neurovascular diseases is expected to drive the growth of the neuroendovascular coil market in the future. Neurovascular diseases affect the blood vessels that supply the nervous system, often leading to neurological symptoms and complications. Neuroendovascular coils are used to treat these diseases by being inserted into blood vessels to block or stabilize abnormal blood vessel structures, thus reducing the risk of bleeding or other complications. For example, in November 2023, a report from the National Board of Health and Welfare (Socialstyrelsen), a Sweden-based government agency, revealed that in 2022, approximately 26,800 strokes were reported, affecting about 25,100 individuals. Of those who suffered a stroke that year, 12% died on the same day, 23% within 28 days, and 34% within one year. Therefore, the rising prevalence of neurovascular diseases is fueling the growth of the neuroendovascular coil market.

The increasing healthcare expenditure is expected to propel the growth of the neuroendovascular coil market moving forward. Healthcare expenditure encompasses spending on healthcare services, including medical goods, public health activities, and administrative costs. Factors driving this growth include an aging population, technological advancements in medicine, rising pharmaceutical costs, and the increasing prevalence of chronic diseases. The rising healthcare expenditure contributes to advancements in neuroendovascular coil technology, promoting innovation, enhancing accessibility, and improving patient outcomes for treating cerebral aneurysms and vascular disorders. For instance, in June 2024, according to *Health Affairs*, a US-based academic journal, national healthcare expenditure in the U.S. is projected to increase from $4.79 trillion in 2023 to $5.04 trillion in 2024, reflecting an increase of around $249.5 billion. As a result, the growing healthcare expenditure is driving the growth of the neuroendovascular coil market.

Major companies in the neuroendovascular coil market are directing their efforts towards the development of soft and unique-shaped coils. In neuroendovascular procedures, these coils, such as tetrahedral coils, enhance aneurysm treatment by conforming to vessel anatomy, reducing complications, and improving patient outcomes, particularly in complex cases. For example, in December 2022, Stryker Corporation, a US-based medical technology company specializing in neuroendovascular coils, introduced the Target Tetra Detachable Coil. This innovative coil combines a new tetrahedral shape and softness level, specifically designed to treat small aneurysms. It provides a 2-in-1 feature with a unique tetrahedral shape that ensures stability in wide-necked aneurysms and a soft helical tail. This shape offers strong memory while remaining soft, making it a suitable choice for treating small aneurysms.

In April 2022, Wallaby Medical LLC, a US-based medical device company focusing on developing therapies for vascular disease, completed the acquisition of Phenox GmbH for approximately $543 million. This strategic move is expected to expand Wallaby Medical's stroke treatment and prevention product pipeline, facilitating accelerated global expansion. Phenox GmbH is a Germany-based provider of neuroendovascular coils and related products.

Major companies operating in the neuroendovascular coil market report are Cardinal Health Inc., Johnson & Johnson Services Inc., Medtronic PLC, Stryker Corporation, Boston Scientific Corporation, B. Braun Melsungen AG, Terumo Corporation, Kaneka Neurovascular USA, W.L. Gore & Associates Inc., Cook Group Incorporated, Merit Medical Systems Inc., MicroPort Scientific Corporation, Penumbra Inc., MicroVention Inc., Medikit Co. Ltd., Minnetronix Medical Inc., SurModics Inc., Galen Medical Group P.C, Balt USA LLC, Acandis GmbH, Rapid Medical Ltd., Allium Medical Solutions Ltd., Shape Memory Medical Inc., InnoCore Pharmaceuticals BV, Wuhan HNC Technology Co. Ltd., Neural Co. Ltd., Three Rivers Medical Inc.

North America was the largest region in the neuroendovascular coil market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the neuroendovascular coil market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the neuroendovascular coil market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The neuroendovascular coil market consists of sales of push able coils, framed coils, complex-shaped coils, micro coils, macro coils, guidewires (used in conjunction with coils), and catheters. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

A neuroendovascular coil is a slender wire that is introduced into blood vessels to obstruct or redirect blood flow in the affected area, facilitating clot formation and preventing further complications. This medical device is primarily employed in the treatment of cerebral aneurysms and other vascular abnormalities.

The key product types within the realm of neuroendovascular coils include Guglielmi detachable coils (GDCs) and matrix coils. Guglielmi detachable coils (GDCs) serve as medical devices utilized in endovascular procedures to address cerebral aneurysms. They work by filling the aneurysm with detachable platinum coils, promoting clotting and averting the risk of rupture. These coils find application in various indications, encompassing both ruptured and unruptured aneurysms. Additionally, GDCs are employed for diverse purposes such as tumor surgery and medical teaching, with end users including hospitals, ambulatory surgical centers (ASCs), stroke centers, and other medical facilities.

The neuroendovascular coil market research report is one of a series of new reports that provides neuroendovascular coil market statistics, including neuroendovascular coil industry global market size, regional shares, competitors with a neuroendovascular coil market share, detailed neuroendovascular coil market segments, market trends and opportunities, and any further data you may need to thrive in the neuroendovascular coil industry. This neuroendovascular coil market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.